Akanda pivots to German market as cannabis reform gains traction
August 31st, 2022
News, Top News
Akanda CEO bullish on Germany as company agrees to provide cannabis to the country’s medical pot market.
Akanda Corp. CEO Tej Virk is pivoting the micro-capitalization cannabis company toward the European Union amid rising interest in the sector as German Chancellor Olaf Scholz continues to push for marijuana legalization.
Virk sees Germany offering regulatory tailwinds as the largest economy in Europe gets ready to set up its adult use cannabis industry in the coming months. Other EU countries may soon follow, he said.
“We’re going to see other countries in the EU watch this carefully,” Virk told MarketWatch. “It’s an exciting time. We’re gearing up our business.”
To boost its business in the EU, Akanda AKAN, 3.53% in May closed its roughly $20 million acquisition of Holigen, owner of Portugal-based RPK Biopharma, which runs a 20,000 square foot indoor grow facility located near Lisbon. It also owns 180-plus acres of outdoor growing space about two hours south.
In early August, Akanda inked a multi-year supply agreement with European medical cannabis importer and distributor Cansativa GmbH to initially deliver a minimum of one metric ton over the first 12 months to the German medical market from its Holigen operation in Portugal.
The deal ranks as one of the largest supply agreements in the European medical cannabis industry, as well as the most substantial commercial development for Akanda since the company was formed in 2021, Virk said.
Akana went public in March in the U.S. on the Nasdaq in a deal that raised $16 million with Bousted Securities LLC.
The German adult use market may tip the scales at about 300 tons of cannabis as early as 2024, according to comments in the press by the German health minister. But the country currently lacks adequate domestic supply to meet demand. It’s likely Germany will accept cannabis produced inside the European Union for its adult use market, but whether imports will be allowed from outside the EU remains unknown, Virk said.
To boost its presence in Portugal and for other efforts, Akanda has hired two new cannabis industry veterans to start work on Sept. 1. Tom Flow will be chief operating officer of Akanda and managing director of Holigen.
Flow was co-founder of MedReleaf Corp. which was sold to Aurora Cannabis Inc. ACB, 3.95% ACB, 4.02% in 2018; he also worked in senior roles at The Flowr Corp. FLWPF, +8.52%.
Steven George, a veteran of Tilray Brands Inc. TLRY, 0.32% TLRY, -0.20% in Spain and Portugal, is joining Akanda as commercial director.
Akanda is currently involved in a legal fight with its former executive chairman Louisa Mojela over the liquidation of its Bophelo Bio Science & Wellness (Pty) Ltd. cannabis grow operation in Lesotho, a country located within South Africa. Virk said in a statement on July 27 that without Bophelo, the company remains on an “accelerated path” to profitability, but it also remains committed to the business.
Citing industry data, Cantor Fitzgerald analyst Pablo Zuanic said earlier this month that Aurora, Cannamedical Pharma GmbH, Canopy Growth Corp. CGC, 0.48% WEED, 0.62%, Four20 Pharma GmbH and Tilray comprised more than 70% of the cannabis flower market in Germany over the last 12 months. Berlin-based Demecan also ranks as a domestic production licensee in Germany.
Meanwhile, Curaleaf Holdings Inc. CURLF, -4.05% CURA, -4.36% announced plans on Aug. 9 to acquire a 55% stake in Four20Pharma for €19.7 million ($19.7 million), to boost its presence in Germany.
With the German adult-use market estimated at $12.6 billion, Cantor Fitzgerald’s Zuanic said Aurora Cannabis and Tilray rank as the best-positioned companies to benefit from the potential market, among the stocks that he covers.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.